ABOUT US

We are a forward-thinking, mid-size contract research organization, offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development including preclinical safety testing, clinical pharmacology, bioanalysis and research services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

The devotion, expertise, and degree of professionalism employed by the (Altasciences) team in all stages of development, and the support provided during the Clinical trial, were unprecedented.

Joanna L Gore, Ph.D., Clinical Research Scientist, Drug Development
Jamie L Doran, MSc, DABT, ERT, VP Drug Development Appili Therapeutics Inc.

RESOURCE CENTER

NEW SCIENTIFIC POSTERS

June 10, 2019

If you missed our poster presentations at the 67th ASMS conference, simply click to download them. No contact information required!

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Careers

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

Related Press Release

Altasciences and WuXi AppTec Enter Into Collaboration for WIND Projects

May 16, 2019

Altasciences will provide its full-service solutions, including clinical pharmacology, first-in-human and proof-of-concept trials, program management, medical writing, biostatistics, and data management to support and conduct comprehensive early phase clinical services for WuXi AppTec’s multiple ongoing WIND programs.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Our Solutions

Newsletters

NEW SCIENTIFIC POSTERS

June 10, 2019

If you missed our poster presentations at the 67th ASMS conference, simply click to download them. No contact information required!

Read More

SELECT A CATEGORY BELOW

NEWSLETTERS

  • Newsletter

    May 2019

    May 29, 2019

    A recent case study, an upcoming webinar and more

  • Newsletter

    March 2019

    Mar 29, 2019

    Bold new look, how to overcome bioanalytical challenges, and case studies on hybrid medicines, 505(b)(2), and drug interactions

  • Newsletter

    September 2018

    Sep 1, 2018

    Get the Scoop – A case study evaluating the abuse potential of Mirogabalin, news on our upcoming acquisition, the top trends influencing the CRO industry, and more!

  • Newsletter

    April 2018

    Apr 30, 2018

    Get the Scoop – A case study on cannabis, our latest assay list, and much more!

  • Newsletter

    January 2018

    Jan 29, 2018

    GET THE SCOOP — Up Close and Personal with our CEO and 5 Ways to Save Money on Outsourcing

  • Newsletter

    June 2017

    Jun 2, 2017

    Guideline on Equivalence Studies, Metabolic Disorders and your chance to ask our experts questions directly about hot topics like Biotherapeutics and Therapeutic Equivalence.

  • Newsletter

    February 2017

    Feb 24, 2017

    Learn about our cannabis study, biosimilars, our diabetes case studies, and so much more!

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.

STAY CONNECTED

2019 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy